Kinvent raised €16M in a funding round in Jan 2024. The company is based in Montpellier, France. Investors in the round: Nov Santé Actions Non Cotées. Data as of 24 Sept 2026.
Reported in EUR — no conversion. €16M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
